# Study to Evaluate the Safety and Effectiveness of GP0116

> **NCT05987163** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Galderma R&D** · enrollment: 186 (estimated)

## Conditions studied

- Skin Manifestations

## Interventions

- **DEVICE:** GP0116
- **DEVICE:** Active Comparator: FDA approved dermal filler device (RHA 3)

## Key facts

- **NCT ID:** NCT05987163
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-12
- **Primary completion:** 2024-10-29
- **Final completion:** 2026-03-31
- **Target enrollment:** 186 (ESTIMATED)
- **Last updated:** 2025-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05987163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05987163, "Study to Evaluate the Safety and Effectiveness of GP0116". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05987163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*